Literature DB >> 19434499

Who purchases nonprescription syringes? Characterizing customers of the Expanded Syringe Access Program (ESAP).

Haven B Battles1, Kirsten A Rowe, Christina Ortega-Peluso, Susan J Klein, James M Tesoriero.   

Abstract

This study represents the first attempt in the USA to survey pharmacy nonprescription syringe customers at their point of purchase. We surveyed 62 individuals purchasing nonprescription syringes in seven pharmacies located in NYC and Albany, NY, USA. Three quarters of respondents purchased for illicit use, and 36% purchased for medical use, with differences found by race and gender. Half got their syringes from pharmacies "most of the time." Half had ever been refused a syringe purchase in a NYS pharmacy, with men, Blacks, and Hispanics reporting higher levels of refusals than women or whites. Two thirds reported syringe reuse but very few reported sharing. While approximately one quarter safely obtained and disposed of syringes "most of the time," two thirds used both safe and unsafe methods. Pharmacy-based syringe access programs are essential in areas not served by syringe exchanges.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434499      PMCID: PMC2791812          DOI: 10.1007/s11524-009-9356-5

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  9 in total

1.  Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.

Authors:  Ricky N Bluthenthal; Mohammed Rehan Malik; Lauretta E Grau; Merrill Singer; Patricia Marshall; Robert Heimer
Journal:  Addiction       Date:  2004-09       Impact factor: 6.526

2.  Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Shannon Blaney; Danielle C Ompad; Sherry Deren; Don Des Jarlais; David Vlahov
Journal:  Ethn Dis       Date:  2004       Impact factor: 1.847

3.  Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.

Authors:  Enrique R Pouget; Sherry Deren; Crystal M Fuller; Shannon Blaney; James M McMahon; Sung-Yeon Kang; Stephanie Tortu; Jonny F Andia; Don C Des Jarlais; David Vlahov
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

4.  Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.

Authors:  Charles M Cleland; Sherry Deren; Crystal M Fuller; Shannon Blaney; James M McMahon; Stephanie Tortu; Don C Des Jarlais; David Vlahov
Journal:  Health Educ Behav       Date:  2006-06-30

5.  The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.

Authors:  Sherry Deren; Charles M Cleland; Crystal Fuller; Sung-Yeon Kang; Don C Des Jarlais; David Vlahov
Journal:  AIDS Behav       Date:  2006-11

6.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Wendy Caceres; Shannon Blaney; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

7.  Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

8.  Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.

Authors:  Don C Des Jarlais; Naomi Braine; Huso Yi; Charles Turner
Journal:  AIDS Educ Prev       Date:  2007-04

9.  Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey.

Authors:  Jennifer McNeely; Julia H Arnsten; Marc N Gourevitch
Journal:  Harm Reduct J       Date:  2006-02-18
  9 in total
  2 in total

1.  Adverse event associated with a change in nonprescription syringe sale policy.

Authors:  Nickolas D Zaller; Michael A Yokell; Alexandra Jeronimo; Jeffrey P Bratberg; Patricia Case; Josiah D Rich
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Sep-Oct

2.  Estimated effect of US state syringe sale policy on source of last-used injection equipment.

Authors:  Patrick Janulis; Barrett W Montgomery; James C Anthony
Journal:  Int J Drug Policy       Date:  2019-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.